Drug · DIN 02223139
NORTRIPTYLINE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since April 6, 2021; first marketed July 23, 1996.
- Drug Identification Number (DIN)
- 02223139
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Nortriptyline N06AA10
- Class
- Human
- Record last updated
- September 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NORTRIPTYLINE (NORTRIPTYLINE HYDROCHLORIDE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 6, 2021: NOC 27051Abbreviated New Drug Submission (ANDS)
- June 7, 1996: NOC 4586Abbreviated New Drug Submission (ANDS)
Other DINs named NORTRIPTYLINE
- DIN 02223147 · Approved
- DIN 02237376 · Cancelled Post Market
- DIN 02237377 · Cancelled Post Market